Pressure on pharmaceuticals companies operating in China intensified yesterday as authorities broadened their probe into drug pricing and corruption.
在華經營的醫藥企業所受到的壓力昨日加劇，相關部門拓寬了其對藥品定價和腐敗行爲的調查。